U.S. market Closed. Opens in 11 hours 51 minutes

TENX | Tenax Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-03-312014-04-302013-04-302012-04-302011-04-302010-04-302009-04-302008-04-302007-04-302006-04-302005-04-302004-04-302003-04-302002-04-302001-04-302000-04-301999-04-301998-04-301997-04-301996-04-30
RevenueN/AN/AN/AN/AN/AN/AN/AN/A49.29K288.73K1.23M415.03K322.35KN/AN/AN/AN/AN/AN/AN/AN/AN/A1.001.00100.00KN/AN/AN/A
Cost of Revenue7.57K113.33K108.98K114.75K107.28KN/AN/AN/AN/A129.80K43.11K51.25K219.18KN/AN/AN/AN/AN/AN/AN/AN/AN/A-71.63K-53.99K-100.00KN/AN/AN/A
Gross Profit-7.57K-113.33K-108.98K-114.75K-107.28KN/AN/AN/A49.29K158.93K1.19M363.78K103.17KN/AN/AN/AN/AN/AN/AN/AN/AN/A71.63K53.99K200.00KN/AN/AN/A
Operating Expenses8.23M11.05M32.73M9.87M8.56M6.89M9.21M19.39M13.83M16.77M6.13M8.55M10.36M10.15M8.60M2.93M1.77M2.48M2.68M2.27M2.27M3.60M2.07M965.59K1.00M1.26M1.90M2.35M
Selling, General & Admin5.00M5.68M7.58M5.31M5.08M5.65M5.68M6.25M7.17M13.77M3.68M6.09M7.68M7.24M7.00M1.99M1.02M1.27M1.41M990.98K840.35K2.29M1.22M687.58K700.00K1.14M1.44M1.42M
Research & Development3.23M5.38M25.15M4.56M3.47M1.24M3.53M13.14M6.66M3.00M2.46M2.46M2.68M2.92M1.60M940.00K752.61K1.20M1.28M1.28M1.43M1.31M782.34K224.02K200.00K111.77K460.98K924.09K
Other Operating ExpensesN/A9.19K254.83K18.17K160.90K79.83K366.22KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A71.63K53.99K100.00KN/AN/AN/A
Operating Income-8.23M-11.05M-32.73M-9.87M-8.56M-6.89M-9.21M-52.65M-13.78M-16.61M-4.94M-8.19M-10.26M-10.15M-8.60M-2.93M-1.77M-2.48M-2.68M-2.27M-2.27M-3.60M-2.00M-911.60K-800.00K-1.26M-1.90M-2.35M
Other Expenses / Income523.27K4.75K253.88K16.54K160.90K79.83K366.22K-32.50M-299.93K-2.93M-4.47M-109.69K-16.10K-199.55K-238.53K-176.58K120.03K67.87K11.81K18.00K48.56K130.29K331.02K16.14KN/A-3.07K-914.00-5.92K
Before Tax Income-7.71M-11.05M-32.47M-9.85M-8.39M-6.81M-8.84M-51.89M-14.08M-19.54M-9.42MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax Expenses1.00-4.75K255.78K19.79K-64.58K-79.83KN/A-7.96MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-7.71M-11.04M-32.73M-9.87M-8.39M-6.73M-8.84M-43.92M-14.08M-19.54M-9.42M-15.71M-10.45M-10.51M-33.22M-6.72M-3.33M-4.07M-2.67M-2.25M-2.23M-3.49M-1.67M-911.34K-800.00K-1.28M-1.91M-2.35M
Interest Expenses23.97K4.44K949.001.63KN/AN/AN/AN/A49.08K2.21M4.24M7.41M171.56K155.00K24.86M3.61M1.68M1.66MN/AN/AN/A13.60K1.07K15.88KN/AN/AN/AN/A
Basic Shares Outstanding248.45K18.39K12.86K6.48K309.77K78.24K70.53K1.41M1.40M468.10K82.51K64.82K58.37K48.71K28.88K23.58K23.04K21.86K19.81K15.89K14.78K14.53K14.40K10.89K8.56K7.67K6.01K4.82K
Diluted Shares Outstanding248.45K18.39K12.86K6.48K309.77K78.24K70.53K1.41M1.40M468.10K87.95K69.38K58.37K48.71K28.88K41.67K23.04K21.86K19.81K15.89K14.78K14.53K14.40K10.89K8.56K7.67K6.01K4.82K
EBITDA-8.23M-10.93M-32.36M-9.74M-8.45M-6.88M-8.83M-19.37M-13.88M-17.18M-5.03M-8.09M-9.97M-10.04M-8.58M-2.83M-1.62M-2.22M-2.42M-2.13M-2.14M-3.49M-1.60M-841.47K-700.00K-1.19M-1.82M-2.25M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-28,171.47%-5,949.95%-407.49%-1,950.12%-3,091.59%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-159,954,500.00%-84,146,500.00%-700.00%0.00%0.00%0.00%
EBIT-7.69M-11.04M-32.47M-9.85M-8.46M-6.81M-8.84M-51.89M-14.03M-17.33M-5.18M-8.30M-10.28M-10.35M-8.36M-3.11M-1.65M-2.41M-2.67M-2.25M-2.23M-3.47M-1.67M-895.46K-800.00K-1.28M-1.91M-2.35M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-28,472.04%-6,002.08%-419.54%-1,999.92%-3,188.08%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-167,117,200.00%-89,545,700.00%-800.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-03-312014-04-302013-04-302012-04-302011-04-302010-04-302009-04-302008-04-302007-04-302006-04-302005-04-302004-04-302003-04-302002-04-302001-04-302000-04-301999-04-301998-04-301997-04-301996-04-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙